Stage 2 Meaningful Use - Detailed Public Health Objectives

EPs, EHs and CAHs must register their intent to submit data and meet active engagement from certified EHR technology.

EHs, CAHs and EPs, must begin by registering their intent to initiate ongoing submission at the IDPH Meaningful Use Registration System: https://murs.illinois.gov on or after October 1, 2013. After registration, a provider will receive an electronic confirmation message. This will serve as documentation of their status for Meaningful Use Stage 2 reporting and will provide additional information to prepare for the on-boarding process. A provider will then be placed in a queue for on-boarding and will await invitation from the Illinois Department of Public Health to begin testing and validation.

The eligible provider can satisfy the active engagement requirement for a public health measure through any of the following:

1. Option 1: Completed Registration of intent to submit data
2. Option 2: Testing and Validation
3. Option 3: Production

The eligible provider will not meet the measure in the following situations:

1. Fails to register their intent by the deadline (within 60 days of the start of the EHR reporting period); or
2. Fails to participate in the on-boarding process as demonstrated by their failure to respond to the IDPH written requests for action within 30 days on two separate occasions.

NOTE: Actual patient data is required for the production.

NOTE: IDPH will provide written communication affirming that the eligible provider was able to submit the relevant public health data to meet the measure. The response will be in writing and may include a response in an electronic format including but not limited to: 1) email sent to provider; 2) letter mailed to provider; 3) HL7 acknowledgement message; 4) posting information to a designated IDPH website. This communication can be used to support provider attestation.

NOTE: For Eligible Hospitals submitting syndromic surveillance data, the following link provides documentation for Option 2 and 3: Syndromic Surveillance Reporting Facilities

Eligible Professionals: Successful ongoing submission of electronic immunization data from certified EHR technology to I-CARE for the entire EHR reporting period.

• EPs may choose to submit data to the ILHIE, which will send it on the Public Health Node for Meaningful Use reporting and submission to I-CARE.

Eligible Hospitals & Critical Access Hospitals: Successful ongoing submission of electronic immunization data from certified EHR technology to I-CARE for the entire the EHR reporting period.

• Hospitals not currently submitting data directly to I-CARE should route that data through the ILHIE, which will send it on to the Public Health Node for Meaningful Use reporting and submission to I-CARE.

Illinois Immunization Use Case: Click Here

* If EPs, or hospitals have achieved ongoing submission prior to CY 2014 and FY 2014, respectively, using EHR technology certified to the 2011 Edition EHR certification criteria (HL7 v2.3.1 only) it is acceptable to continue this ongoing submission and meet Stage 2.

Step 1: Click here to register intent to initiate ongoing submission. If the eligible provider fails to register their intent to initiate ongoing submission by the deadline they will not meet the measure.

Step 2: Register with I-CARE using the IDPH Registration Site

Step 3: Sign required legal agreements

• Data Use Agreements with IDPH for I-CARE
  • Individual Use Agreement
  • Provider User Agreement
• ILHIE Public Health Data Conduit Agreement, in addition to Data Use Agreements with IDPH for I-CARE
• Note: Hospitals and EPs connected to a Regional HIE supporting public health reporting via the ILHIE are not required to execute a separate Public Health Conduit Agreement.

Step 4: Establish a connection for data exchange (one option required):

• HL7 2.5.1 message from an ONC-Authorized Testing and Certification Bodies (ATCBs) certified system to I-CARE (preferred format)
• Connectivity through a Regional Health Information Exchange supporting public health reporting via the ILHIE.
• Note: Facilities that send data in the preferred HL7 format are prioritized. Facilities that are unable to send data in the preferred format please email the ILHIE here:

Step 5: Submission of Test Message

• Review test message data content
• Validate data with I-CARE's (Public Health Node) HL7 parser
• Test data in I-CARE (Public Health Node) Test environment
• Test data in I-CARE (Public Health Node) Development environment

Step 6: Validation of Data Content

• Test and validate the data in I-CARE (Public Health Node) Production environment

Step 7: Ongoing Submission

Applicable Exclusion Criteria: An EP, EH or CAH that administers no immunizations during the EHR reporting period.

Eligible Professionals: Not a Meaningful Use option for EPs

Eligible Hospitals & Critical Access Hospitals: Successful ongoing submission of electronic reportable laboratory results from certified EHR technology to I-NEDSS for the entire EHR reporting period.

• Hospitals not currently submitting data directly to IDPH should route that data through the ILHIE, which will send it on to the Public Health Node for Meaningful Use reporting and submission to I-NEDSS.

Illinois Electronic Laboratory Reporting Use Case v1.1: Click Here

Step 1: Click here to register intent to initiate ongoing submission. If the eligible provider fails to register their intent to initiate ongoing submission by the deadline they will not meet the measure.

Step 2: Sign required legal agreements:

• ILHIE Public Health Data Conduit Agreement
• Note: Hospitals and EPs connected to a Regional HIE supporting public health reporting via the ILHIE are not required to execute a separate Public Health Conduit Agreement.

Step 3: Establish a Connection for Data Exchange (one option required):

• HL7 2.5.1 message from an ONC-Authorized Testing and Certification Bodies (ATCBs) certified system to I-NEDSS (preferred format)
• Connectivity through a Regional Health Information Exchange supporting public health reporting via the ILHIE.
• Note: Facilities that send data in the preferred HL7 format are prioritized. Facilities that are unable to send data in the preferred format please email the ILHIE here

Step 4: Submission of Test Message

• Review and validate hospital codes and data content
• Test data in Public Health Node/I-NEDSS Development environment
• Test data in Public Health Node/I-NEDSS Test environment

Step 5: Validation of Data Content

• Validation of data in Public Health Node/I-NEDSS Production environment

Step 6: Ongoing Submission

[Updated: November 17, 2015]

Eligible Hospitals & Critical Access Hospitals: IDPH accepts ongoing submission of electronic syndromic surveillance data.

• For a current list of EHs submitting syndromic surveillance data, the following link provides documentation for testing and validation or production:
  Syndromic Surveillance Reporting Facilities
  

  Hospitals should notify IDPH when changes to their EHR affect their syndromic surveillance interface, including: upgrades to the EHR system, change in EHR vendor, or begin using 2015 ONC certified syndromic surveillance interface.

Public Health Memo RE: New Syndromic Surveillance Reporting Requirements as of March 21, 2013:

• IDPH now requires Acute Care and Critical Access Hospitals not already submitting Emergency Department syndromic surveillance data to IDPH that meet Meaningful Use Stage 2 specifications to begin doing so by March 1, 2014 in the City of Chicago and counties with populations > 500,000 residents and by September 1, 2014 in counties with populations < 500,000 residents.

Note: Hospitals in northeastern Illinois participating in the ESSENCE syndromic surveillance system housed at Cook County Department of Public Health are grandfathered into syndromic surveillance until 2016 to fulfill Meaningful Use requirements by having their syndromic surveillance data routed from ESSENCE to BioSense. Beginning in January, 2016, if you have not yet contacted ILHIE or IDPH to establish an HL7, Meaningful Use submission, IDPH will contact you. Progress to achieve production with an HL7 feed should begin in January, 2016.

Hospitals participating in the Gateway ESSENCE syndromic surveillance system are already in the process of sending syndromic surveillance data to IDPH, in order to fulfill IDPH reporting requirements.

Eligible Professionals:

• IDPH will accept syndromic surveillance data from EPs in urgent care settings only.

EPs in urgent care settings can register. You will be placed in the queue and should await invitation to on-board before taking further steps to implement a syndromic surveillance interface.

Note: IDPH has clarified its declaration of which EPs it will accept syndromic surveillance from based on Meaningful Use Modified Rules for 2015-2017 and Meaningful Use Stage 3.

If the EP has previously registered for syndromic surveillance, follow these guidelines:

Eligible Professionals in urgent care settings should re-register their intent to submit data for syndromic surveillance, if their previous registration indicated a category of provider or practice setting that was NOT urgent care OR if no practice type was indicated. You can also send an email to DPH.MUSS@illinois.gov to confirm that you are an EP practicing in an urgent care setting, and we can verify or amend this information in the registration system.

If you are an EP practicing in an non-urgent care setting, have registered and have not received an invitation for testing and validation, then your practice was reviewed and is not in a category of provider from which IDPH will accept data.

If you are an EP that was already invited to on-board and were in the testing and validation stage as part of a medical study pilot will be contacted directly for further information about their status.

Note: If you are an EP practicing in a non-urgent care setting, registration is not necessary.

For questions pertaining to attestation for Meaningful Use, please refer to the references on the main public health reporting page: http://dph.illinois.gov/topics-services/provider-partner-resources/public-health-reporting, or contact meaningfuluse@cdc.gov.

Eligible Professionals: Successful ongoing submission of cancer case information from certified EHR technology to the Illinois State Cancer Registry for the entire EHR reporting period.

Eligible Hospitals & Critical Access Hospitals: Not a Meaningful Use option for hospitals.

Step 1: Click here to register intent to initiate ongoing submission. If the EP fails to register their intent to initiate ongoing submission by the deadline they will not meet the measure.

Step 2: Establish a Connection for Data Exchange (one option required):

• HL7 CDA from an ONC-Authorized Testing and Certification Bodies (ATCBs) certified system to the Illinois State Cancer Registry

Step 3: Submission of Test Message

• Successful receipt and processing of file by the Cancer Registry

Step 4: Validation of Data Content

• Verification that all required data elements are sent

Step 5: Ongoing Submission

Applicable Exclusion Criteria: The EP does not diagnose or directly treat cancer.

Eligible Professionals: Successful ongoing submission of current potential patients of controlled substances as well as receive and display patient prescription history from certified EHR technology for the entire EHR reporting period.

Eligible Hospitals & Critical Access Hospitals: Successful ongoing submission of current potential patients of controlled substances as well as receive and display patient prescription history from certified EHR technology for the entire EHR reporting period.

Step 1: Click here to register intent to initiate ongoing submission. If the EP fails to register their intent to initiate ongoing submission by the deadline they will not meet the measure.

Step 2: Establish a Connection for Data Exchange (one option required):

• SOAP based web service which uses a PMIX based protocol
• A RESTFUL based web service which uses the NCPDP protocol

Step 3: Submission of Test Message

• Successful receipt and processing of file by the Illinois Prescription Monitoring Program

Step 4: Go Live!

• Following successful testing, activation in the production environment will occur

Step 5: Ongoing Submission